Increased incidence of symptomatic cholesterol cholelithiasis in perimenopausal women receiving estrogen replacement therapy: a retrospective study.
D000328:Adult; D002779:Cholestasis / Q000209:etiology*; D002784:Cholesterol; D045166:Estradiol Congeners / Q000009:adverse effects*; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D012306:Risk
D045166:Estradiol Congeners; D004966:Estrogens, Conjugated (USP); D002784:Cholesterol